Topical methotrexate-loaded nanoparticles for the treatment of vitiligo:a clinical trial

Not Applicable

Recruiting

• Conditions: Skin and Connective Tissue Diseases; vitiligo

• Registration Number: PACTR201804003289316
• Lead Sponsor: alazhar university ,faculty of medicine for girls

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Vitiligo patients who don't use any systemic or local medication for at least one month prior to the onset of the study.
-Age more than 18 years
-both males and females

Exclusion Criteria

-Patients have systemic diseases(e.g. pulmonary diseases, hepatic diseases, neutropenia,anemia,pancytopenia)
-Patients have a history or an active infection with Hepatitis C.
-Pregnant and lactating females
-Patients with age less than 18
-Patients suffering from any dermatological disease other than vitiligo.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
-To evaluate the safety and efficacy of methotrexate loaded nano biopolymer as atopical treatment for vitiligo.

Secondary Outcome Measures

Name	Time	Method
To assess the possibility of methotrexate loaded nano biopolymer to be an alternative for conventional vitiligo treatments.